Hardwyn India Ltd vs Q Line Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Hardwyn India Ltd is ₹ 9.08 as of 23 Oct 15:30 . The P/E Ratio of Hardwyn India Ltd changed from 72 on March 2023 to 0 on March 2026 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of Q-Line Biotech Ltd changed from 0 on March 2023 to 0 on March 2026 . This represents a CAGR of 0.0% over 4 years The Market Cap of Hardwyn India Ltd changed from ₹ 668.81 crore on March 2023 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 4 yearsThe Market Cap of Q-Line Biotech Ltd changed from ₹ 0 crore on March 2023 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 4 years The revenue of Hardwyn India Ltd for the Jun '26 is ₹ 34.63 crore as compare to the Mar '26 revenue of ₹ 57.47 crore. This represent the decline of -39.74% The revenue of Q-Line Biotech Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 110.94 crore. This represent the decline of -100% The ebitda of Hardwyn India Ltd for the Jun '26 is ₹ 4.53 crore as compare to the Mar '26 ebitda of ₹ 6.04 crore. This represent the decline of -25% The ebitda of Q-Line Biotech Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 33.57 crore. This represent the decline of -100% The net profit of Hardwyn India Ltd changed from ₹ 1.34 crore to ₹ 2.8 crore over 9 quarters. This represents a CAGR of 38.75% The net profit of Q-Line Biotech Ltd changed from ₹ 17.38 crore to ₹ 0 crore over 3 quarters. This represents a CAGR of -100.00% The Dividend Payout of Hardwyn India Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Q-Line Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Hardwyn India Ltd

Hardwyn India Limited was originally incorporated with the name of Garv Industries Limited as a Limited Company on October 12, 2017.
The Promoter, Mr. Rishu Agarwal was involved in trading of aluminum products in Delhi from 1996 through his H.U.F till 2008.
Another Promoter, Mrs. Daya Bansal managed a proprietorship firm known as 'Indian Sales Corporation' which engaged in the business of fabrics trading from April, 2011 to March, 2013.
The name of the Company was changed to Hardwyn India Limited in January 2020. The Company came up with a Public Issue of 32,00,000 Equity Shares by raising capital aggregating Rs 3.2 Crore in April, 2018. The Company is promoted by Rishu Agarwal and family who have been in this business through family proprietary concerns, proprietary business and through partnership.

About Q-Line Biotech Ltd

Q-Line Biotech Limited was originally incorporated as 'POCT Services Private Limited' on November 10, 2010 as a Private limited company dated November 10, 2010 issued by the Assistant Registrar of Companies, Uttar Pradesh and Uttarakhand.
Subsequently, the name of Company was changed to 'Q-Line Biotech Private Limited on July 23, 2021.
Further, Company was converted from a private company to public company and the name of Company was changed to 'Q-Line Biotech Limited', via fresh certificate of incorporation dated March 08, 2025 issued by Central Processing Centre. The Company is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs.

FAQs for the comparison of Hardwyn India Ltd and Q-Line Biotech Ltd

Which company has a larger market capitalization, Hardwyn India Ltd or Q-Line Biotech Ltd?

Market cap of Hardwyn India Ltd is 620 Cr while Market cap of Q-Line Biotech Ltd is 1,235 Cr

What are the key factors driving the stock performance of Hardwyn India Ltd and Q-Line Biotech Ltd?

The stock performance of Hardwyn India Ltd and Q-Line Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Hardwyn India Ltd and Q-Line Biotech Ltd?

As of October 25, 2026, the Hardwyn India Ltd stock price is INR ₹9.08. On the other hand, Q-Line Biotech Ltd stock price is INR ₹529.55.

How do dividend payouts of Hardwyn India Ltd and Q-Line Biotech Ltd compare?

To compare the dividend payouts of Hardwyn India Ltd and Q-Line Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.